| Particulars |
|
|
|
|
Company Name
| Bafna Pharmaceuticals Ltd
|
Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
23.66 |
B.V. (₹) |
40.60 |
| Sales(₹ Cr.) |
150.62 |
NP (₹ Cr.) |
11.10 |
| NP Var% |
74.00 |
Div% |
0.00 |
| CPS(₹) |
7.30 |
EPS (₹) |
4.70 |
| Traded Value(₹ Lakhs) |
1.82 |
52 Week High |
216.00 |
| 52 Week Low |
74.00 |
Price BSE |
150.00 |
| Price NSE |
149.00 |
Market Capital (₹ Cr.) |
355.08 |
| P/C Ratio |
20.70 |
P/E Ratio |
32.00 |
| Price Vs.BV |
3.69 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
42.24 |
| NP(₹ Cr.) |
2.75 |
NP Var % |
-11.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
143.45 |
| OPM |
3.81 |
NP |
0.75 |
| NP Var% |
74.18 |
EPS |
4.69 |
| PE |
32.00 |
|
|